Carclo plc

Carclo plc

CCEGF
Carclo plcUS flagOther OTC
0.67
USD
-NaN
- -
49.19MMarket Cap
Carclo plc
CCEGF
(Other OTC)

Recent

price

0.67

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
FRC
1.44
1.51
1.35
1.48
1.63
1.8
1.99
2
1.44
1.51
1.47
1.75
1.95
1.81
1.65
1.56
Revenue per Share
0.1
0.08
0.04
0.05
-0.33
0.03
0.12
0.12
-0.25
-0.16
0.1
0.08
-0.05
-0.05
0.01
0.04
Basic EPS, GAAP
-0.05
0.04
-0.03
-0.1
-0.09
0.03
-0.03
-0.08
-0.07
0.15
0.01
-0.03
0.02
0.1
0.14
0.02
Free Cash Flow per Basic Share
0.02
0.02
0.02
0.03
0.03
0.03
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.88
0.71
0.98
1.12
0.62
0.5
0.61
0.71
0.17
0.12
0.11
0.33
0.16
0.04
-0.16
-0.12
Book Value per Share
0.29
0.05
0.3
0.42
0.23
0.19
0.25
0.36
-0.16
-0.19
-0.19
0.02
-0.16
-0.26
-0.46
-0.42
Tangible Book Value per Share
61
62
64
66
66
66
69
73
73
73
73
73
73
73
73
73
Basic Weighted Avg Shares
89
93
87
97
108
119
138
146
105
111
108
129
143
133
121
114
Sales/Revenue/Turnover
6.65
7.19
6.47
6.45
7.05
8.29
9.36
7.39
6
6.32
5.21
4.91
3.53
4.96
8.31
11.02
Operating Margin (%)
4
4
4
5
4
4
5
5
6
7
6
7
8
8
7
6
Depreciation Expense
6
5
3
4
-22
2
8
8
-19
-11
7
6
-4
-3
1
3
Net Income, GAAP
11.37
15.57
12.68
24.71
- -
43.85
23.82
- -
- -
- -
6.85
13.68
- -
- -
67.12
44.23
Effective Tax Rate (%)
6.67
4.97
3.2
3.7
-20.41
1.85
5.78
5.81
-17.69
-10.32
6.89
4.51
-2.76
-2.55
0.72
2.36
Profit Margin (%)
14
13
18
12
22
26
33
35
-1
-9
23
29
21
9
-10
9
Working Capital
19
19
18
18
30
31
29
29
1
4
38
42
40
29
5
22
LT Debt
54
45
65
75
41
33
44
52
12
9
8
24
12
3
-12
-9
Total Equity
6.62
7
5.77
4.69
- -
6.95
11.2
- -
- -
- -
9.36
8.83
- -
- -
10.51
33.78
Return on Invested Capital (%)
8.31
15.81
5.26
4.73
- -
3.9
11.09
- -
- -
- -
18.51
14.06
- -
- -
8.77
35.1
Return on Capital (%)
11.96
9.42
5.11
5.22
-38.13
5.93
20.72
17.63
-57.92
-108.4
88.8
35.82
-21.94
-45.96
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-48.96%
-85.43%
-26.78%
Free Cash Flow
-54.12%
-11.27%
-87.57%
Net Income, GAAP
-37.45%
-24.2%
209.06%
Sales/Revenue/Turnover
0.54%
1.83%
-5.78%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
133
2025
- -
- -
- -
- -
121
2026
- -
- -
- -
- -
114

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.05
2025
- -
- -
- -
- -
0.01
2026
- -
- -
- -
- -
0.04

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Carclo plc Carclo plc (Ticker: CCEGF) manufactures precision-engineered plastic components and assemblies for life sciences, aerospace, and optics sectors; offers in vitro diagnostics and medical devices including microfluidic components, pipettes, cuvettes, multiwells, and capillary blood sampling devices; drug delivery systems; precision injection mouldings, automation, assembly, printing, and supply chain solutions; aerospace cables, wires, machined critical components; LED lighting solutions such as aftermarket automotive lighting and Fresnel lenses; and visual aids under the Coil brand for eye care optics. The company operates through two main segments, Carclo Technical Plastics (CTP), which provides value-added engineered solutions for life science and precision industries, and the Specialty Division, which delivers components for aerospace, optical, and light & motion applications. Founded in 1924 and headquartered in Mitcham, Surrey, United Kingdom, Carclo maintains a global footprint with manufacturing facilities across EMEA, Americas, and APAC regions including the UK, Czech Republic, US (Pennsylvania), and India. Recent strategic developments include the completion of US operations restructuring with the closure of Tucson and Derry facilities in 2024-2025, consolidating manufacturing into Pennsylvania for enhanced efficiency; integration of Aerospace and Light & Motion into the Specialty Division with a refocus on higher-value precision solutions, driving 20.6% revenue growth and 19.7% return on sales in FY25; refinancing of primary borrowing facilities in April 2025 with BZ Commercial Finance DAC for a three-year £36m multi-currency agreement comprising a £27m term loan and £9m revolving credit facility; agreement on UK defined benefit pension scheme deficit recovery with a £5.1m lump sum payment and £3.5m annual contributions through 2029; expansion of strategic partnerships for process optimization, back-end automation, and material utilization improvements; a major five-year customer contract renewal in July 2025 enhancing medium-term revenue visibility; and investments in geographical expansion targeting complex precision moulding and automated assembly for in vitro diagnostics in India and South Asia.

Company News

APIChatGPT